Disease mechanisms as subtypes: Lysosomal dysfunction in the endolysosomal Parkinson's disease subtype

Alcalay, 2015, Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations, Brain, 138, 2648, 10.1093/brain/awv179 Alcalay, 2018, Alpha galactosidase A activity in Parkinson's disease, Neurobiol Dis, 112, 85, 10.1016/j.nbd.2018.01.012 Alvarez-Erviti, 2010, Chaperone-mediated autophagy markers in Parkinson disease brains, Arch Neurol, 67, 1464, 10.1001/archneurol.2010.198 Amaral, 2018, Lysosomal Cathepsin release is required for NLRP3-inflammasome activation by mycobacterium tuberculosis in infected macrophages, Front Immunol, 9, 1427, 10.3389/fimmu.2018.01427 Ando, 2012, VPS35 mutation in Japanese patients with typical Parkinson's disease, Mov Disord, 27, 1413, 10.1002/mds.25145 Baba, 2005, Alterations of T-lymphocyte populations in Parkinson disease, Parkinsonism Relat Disord, 11, 493, 10.1016/j.parkreldis.2005.07.005 Bai, 2015, Role of acid sphingomyelinase bioactivity in human CD4+ T-cell activation and immune responses, Cell Death Dis, 6, e1828, 10.1038/cddis.2015.178 Bainton, 1981, The discovery of lysosomes, J Cell Biol, 91, 66s, 10.1083/jcb.91.3.66s Ballabio, 2020, Lysosomes as dynamic regulators of cell and organismal homeostasis, Nat Rev Mol Cell Biol, 21, 101, 10.1038/s41580-019-0185-4 Bayer, 1999, Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores, Neurosci Lett, 266, 213, 10.1016/S0304-3940(99)00311-0 Beilina, 2014, Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease, Proc Natl Acad Sci U S A, 111, 2626, 10.1073/pnas.1318306111 Beilina, 2020, The Parkinson's disease protein LRRK2 interacts with the GARP complex to promote retrograde transport to the trans-Golgi network, Cell Rep, 31, 10.1016/j.celrep.2020.107614 Boecker, 2021, Hyperactive LRRK2 kinase impairs the trafficking of axonal autophagosomes, Autophagy, 17, 2043, 10.1080/15548627.2021.1936933 Bonet-Ponce, 2020, LRRK2 mediates tubulation and vesicle sorting from lysosomes, Sci Adv, 6, 10.1126/sciadv.abb2454 Braak, 2017, Neuropathological staging of brain pathology in sporadic Parkinson's disease: separating the wheat from the chaff, J Parkinsons Dis, 7, S71, 10.3233/JPD-179001 Brochard, 2009, Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease, J Clin Invest, 119, 182 Budge, 2020, Transgenic overexpression of GPNMB protects against MPTP-induced neurodegeneration, Mol Neurobiol, 57, 2920, 10.1007/s12035-020-01921-6 Cen, 2017, Peripheral lymphocyte subsets as a marker of Parkinson's disease in a Chinese population, Neurosci Bull, 33, 493, 10.1007/s12264-017-0163-9 Chen, 2017, Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson's disease patients, Neurosci Lett, 648, 21, 10.1016/j.neulet.2017.03.045 Chen, 2021, Evidence for peripheral immune activation in Parkinson's disease, Front Aging Neurosci, 13, 10.3389/fnagi.2021.617370 Choi, 2015, FcgammaRIIB mediates the inhibitory effect of aggregated alpha-synuclein on microglial phagocytosis, Neurobiol Dis, 83, 90, 10.1016/j.nbd.2015.08.025 Chu, 2009, Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions, Neurobiol Dis, 35, 385, 10.1016/j.nbd.2009.05.023 Clark, 2015, Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease, PLoS One, 10, 10.1371/journal.pone.0125204 Colombo, 2016, Astrocytes: key regulators of neuroinflammation, Trends Immunol, 37, 608, 10.1016/j.it.2016.06.006 Cook, 2017, LRRK2 levels in immune cells are increased in Parkinson's disease, NPJ Parkinsons Dis, 3, 11, 10.1038/s41531-017-0010-8 Cuervo, 2004, Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy, Science, 305, 1292, 10.1126/science.1101738 Dagan, 2015, The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews, Parkinsonism Relat Disord, 21, 1067, 10.1016/j.parkreldis.2015.06.016 Decressac, 2013, TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity, Proc Natl Acad Sci U S A, 110, E1817, 10.1073/pnas.1305623110 Dehay, 2010, Pathogenic lysosomal depletion in Parkinson's disease, J Neurosci, 30, 12535, 10.1523/JNEUROSCI.1920-10.2010 Dehay, 2012, Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration, Proc Natl Acad Sci U S A, 109, 9611, 10.1073/pnas.1112368109 Depboylu, 2012, Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease, Exp Neurol, 238, 183, 10.1016/j.expneurol.2012.08.020 Eguchi, 2018, LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis, Proc Natl Acad Sci U S A, 115, E9115, 10.1073/pnas.1812196115 Espay, 2019, Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases, Neurology, 92, 329, 10.1212/WNL.0000000000006926 Farfel-Becker, 2019, Neuronal soma-derived degradative lysosomes are continuously delivered to distal axons to maintain local degradation capacity, Cell Rep, 28, 51, 10.1016/j.celrep.2019.06.013 Fernandes, 2016, ER stress and autophagic perturbations lead to elevated extracellular α-synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons, Stem Cell Rep, 6, 342, 10.1016/j.stemcr.2016.01.013 Follett, 2014, The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer, Traffic, 15, 230, 10.1111/tra.12136 Foo, 2013, Rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson's disease, Neurobiol Aging, 34, 2890, 10.1016/j.neurobiolaging.2013.06.010 Fujimoto, 2018, Parkinson's disease-associated mutant LRRK2 phosphorylates Rab7L1 and modifies trans-Golgi morphology, Biochem Biophys Res Commun, 495, 1708, 10.1016/j.bbrc.2017.12.024 Funayama, 2002, A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1, Ann Neurol, 51, 296, 10.1002/ana.10113 Gan-Or, 2015, The emerging role of SMPD1 mutations in Parkinson's disease: implications for future studies, Parkinsonism Relat Disord, 21, 1294, 10.1016/j.parkreldis.2015.08.018 Gardai, 2013, Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease, PLoS One, 8, 10.1371/journal.pone.0071634 Gardet, 2010, LRRK2 is involved in the IFN-gamma response and host response to pathogens, J Immunol, 185, 5577, 10.4049/jimmunol.1000548 Giasson, 2001, A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly, J Biol Chem, 276, 2380, 10.1074/jbc.M008919200 Gitler, 2008, The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis, Proc Natl Acad Sci U S A, 105, 145, 10.1073/pnas.0710685105 Gomez-Suaga, 2014, LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity, Hum Mol Genet, 23, 6779, 10.1093/hmg/ddu395 Goody, 2017, Mechanisms of action of Rab proteins, key regulators of intracellular vesicular transport, Biol Chem, 398, 565, 10.1515/hsz-2016-0274 Gordon, 2018, Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice, Sci Transl Med, 10, 10.1126/scitranslmed.aah4066 Gowrishankar, 2015, Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques, Proc Natl Acad Sci U S A, 112, E3699, 10.1073/pnas.1510329112 Grozdanov, 2014, Inflammatory dysregulation of blood monocytes in Parkinson's disease patients, Acta Neuropathol, 128, 651, 10.1007/s00401-014-1345-4 Guardia-Laguarta, 2014, Alpha-synuclein is localized to mitochondria-associated ER membranes, J Neurosci, 34, 249, 10.1523/JNEUROSCI.2507-13.2014 Guo, 2019, TREM2 deficiency aggravates α-synuclein–induced neurodegeneration and neuroinflammation in Parkinson's disease models, FASEB J, 33, 12164, 10.1096/fj.201900992R Haenseler, 2017, Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages, Sci Rep, 7, 10.1038/s41598-017-09362-3 Hartlova, 2018, LRRK2 is a negative regulator of Mycobacterium tuberculosis phagosome maturation in macrophages, EMBO J, 37, 10.15252/embj.201798694 Heaton, 2020, Sequential screening nominates the Parkinson's disease associated kinase LRRK2 as a regulator of Clathrin-mediated endocytosis, Neurobiol Dis, 141, 10.1016/j.nbd.2020.104948 Henry, 2015, Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression, Hum Mol Genet, 24, 6013, 10.1093/hmg/ddv314 Heo, 2010, Coordinate regulation of neurite outgrowth by LRRK2 and its interactor, Rab5, Exp Neurobiol, 19, 97, 10.5607/en.2010.19.2.97 Herbst, 2019, LRRK2 in infection: friend or foe?, ACS Infect Dis, 5, 809, 10.1021/acsinfecdis.9b00051 Herbst, 2020, LRRK2 activation controls the repair of damaged endomembranes in macrophages, EMBO J, 39, 10.15252/embj.2020104494 Hipolito, 2018, Lysosome remodelling and adaptation during phagocyte activation, Cell Microbiol, 20, 10.1111/cmi.12824 Hockey, 2014, Dysregulation of lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition, J Cell Sci, 128, 232 Hoenen, 2016, Alpha-Synuclein proteins promote pro-inflammatory cascades in microglia: stronger effects of the A53T mutant, PLoS One, 11, 10.1371/journal.pone.0162717 Hollenbeck, 1993, Products of endocytosis and autophagy are retrieved from axons by regulated retrograde organelle transport, J Cell Biol, 121, 305, 10.1083/jcb.121.2.305 Horinouchi, 1995, Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease, Nat Genet, 10, 288, 10.1038/ng0795-288 Imamura, 2003, Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains, Acta Neuropathol, 106, 518, 10.1007/s00401-003-0766-2 Inpanathan, 2019, The lysosome signaling platform: adapting with the times, Front Cell Dev Biol, 7, 113, 10.3389/fcell.2019.00113 Jao, 2008, Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement, Proc Natl Acad Sci U S A, 105, 19666, 10.1073/pnas.0807826105 Jenkins, 2010, The synapse and cytolytic machinery of cytotoxic T cells, Curr Opin Immunol, 22, 308, 10.1016/j.coi.2010.02.008 Jeong, 2018, Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration, Mol Neurodegener, 13, 8, 10.1186/s13024-018-0240-1 Jinn, 2017, TMEM175 deficiency impairs lysosomal and mitochondrial function and increases alpha-synuclein aggregation, Proc Natl Acad Sci U S A, 114, 2389, 10.1073/pnas.1616332114 Kawabori, 2015, Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke, J Neurosci, 35, 3384, 10.1523/JNEUROSCI.2620-14.2015 Kim, 2018, Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson's disease, Proc Natl Acad Sci, 115, E5164, 10.1073/pnas.1718946115 Kluss, 2021, Preclinical modeling of chronic inhibition of the Parkinson's disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo, Mol Neurodegener, 16, 17, 10.1186/s13024-021-00441-8 Kumaran, 2015, Pathways to parkinsonism redux: convergent pathobiological mechanisms in genetics of Parkinson's disease, Hum Mol Genet, 24, R32, 10.1093/hmg/ddv236 Kuwahara, 2020, Roles of lysosomotropic agents on LRRK2 activation and Rab10 phosphorylation, Neurobiol Dis, 145, 10.1016/j.nbd.2020.105081 Lecca, 2018, Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARgamma agonist MDG548 in Parkinson's disease models, Br J Pharmacol, 175, 3298, 10.1111/bph.14214 Lee, 2011, Human α-synuclein modulates vesicle trafficking through its interaction with prenylated Rab acceptor protein 1, Biochem Biophys Res Commun., 412, 526, 10.1016/j.bbrc.2011.07.028 Lee, 2020, LRRK2 is recruited to phagosomes and co-recruits RAB8 and RAB10 in human pluripotent stem cell-derived macrophages, Stem Cell Rep, 14, 940, 10.1016/j.stemcr.2020.04.001 Li, 2016, A molecular mechanism to regulate lysosome motility for lysosome positioning and tubulation, Nat Cell Biol, 18, 404, 10.1038/ncb3324 Linford, 2012, Rab14 and its exchange factor FAM116 link endocytic recycling and adherens junction stability in migrating cells, Dev Cell, 22, 952, 10.1016/j.devcel.2012.04.010 Linhart, 2014, Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson's disease mutant of leucine-rich repeat kinase 2 (LRRK2), Mol Neurodegener, 9, 23, 10.1186/1750-1326-9-23 Lira, 2011, Involvement of the Fcγ receptor in a chronic N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of dopaminergic loss, J Biol Chem, 286, 28783, 10.1074/jbc.M111.244830 Liu, 2017, LRRK2 promotes the activation of NLRC4 inflammasome during Salmonella typhimurium infection, J Exp Med, 214, 3051, 10.1084/jem.20170014 Liu, 2021, Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegeneration, Sci Signal, 14, 10.1126/scisignal.abg3555 Lombardi, 1993, Rab9 functions in transport between late endosomes and the trans Golgi network, EMBO J, 12, 677, 10.1002/j.1460-2075.1993.tb05701.x Maas, 2017, Endogenous leucine-rich repeat kinase 2 slows synaptic vesicle recycling in striatal neurons, Front Synaptic Neurosci, 9, 5, 10.3389/fnsyn.2017.00005 Macleod, 2013, RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk, Neuron, 77, 425, 10.1016/j.neuron.2012.11.033 Maday, 2012, Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons, J Cell Biol, 196, 407, 10.1083/jcb.201106120 Mahul-Mellier, 2020, The process of Lewy body formation, rather than simply alpha-synuclein fibrillization, is one of the major drivers of neurodegeneration, Proc Natl Acad Sci U S A, 117, 4971, 10.1073/pnas.1913904117 Mamais, 2021, Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia, PLoS Biol, 19, 10.1371/journal.pbio.3001480 Manocha, 2017, Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice, Mol Neurodegener, 12, 17, 10.1186/s13024-017-0158-z Mantegazza, 2014, TLR-dependent phagosome tubulation in dendritic cells promotes phagosome cross-talk to optimize MHC-II antigen presentation, Proc Natl Acad Sci, 111, 15508, 10.1073/pnas.1412998111 Marinova-Mutafchieva, 2009, Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease, J Neurochem, 110, 966, 10.1111/j.1471-4159.2009.06189.x Marker, 2012, LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein, J Neuroinflammation, 9, 261, 10.1186/1742-2094-9-261 Marshall, 2018, An introduction to immunology and immunopathology, Allergy Asthma Clin Immunol, 14, 10.1186/s13223-018-0278-1 Martin-Bastida, 2017, Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease, Sci Rep, 7, 1398, 10.1038/s41598-017-01402-2 Matteoni, 1987, Translocation and clustering of endosomes and lysosomes depends on microtubules, J Cell Biol, 105, 1253, 10.1083/jcb.105.3.1253 Mazzulli, 2011, Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies, Cell, 146, 37, 10.1016/j.cell.2011.06.001 Mcgeer, 1988, Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains, Neurology, 38, 1285, 10.1212/WNL.38.8.1285 McGough, 2014, Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation, Curr Biol, 24, 1678, 10.1016/j.cub.2014.07.004 Meng, 2020, Cholesterol handling in lysosomes and beyond, Trends Cell Biol, 30, 452, 10.1016/j.tcb.2020.02.007 Michelet, 2015, MHC class II presentation is controlled by the lysosomal small GTPase, Arl8b, J Immunol, 194, 2079, 10.4049/jimmunol.1401072 Mir, 2018, The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human, Biochem J, 475, 1861, 10.1042/BCJ20180248 Miura, 2014, VPS35 dysfunction impairs lysosomal degradation of alpha-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease, Neurobiol Dis, 71, 1, 10.1016/j.nbd.2014.07.014 Moehle, 2012, LRRK2 inhibition attenuates microglial inflammatory responses, J Neurosci, 32, 1602, 10.1523/JNEUROSCI.5601-11.2012 Moehle, 2015, The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins, Hum Mol Genet, 24, 4250, 10.1093/hmg/ddv157 Moloney, 2018, The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress, Neurobiol Dis, 120, 1, 10.1016/j.nbd.2018.08.013 Mrakovic, 2012, Rab7 and Arl8 GTPases are necessary for lysosome tubulation in macrophages, Traffic, 13, 1667, 10.1111/tra.12003 Napolitano, 2016, TFEB at a glance, J Cell Sci, 129, 2475 Nash, 2017, DJ-1 deficiency impairs autophagy and reduces alpha-synuclein phagocytosis by microglia, J Neurochem, 143, 584, 10.1111/jnc.14222 Neumann, 2009, Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease, Brain, 132, 1783, 10.1093/brain/awp044 Ojha, 2016, β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease, Mol Cell Biochem, 418, 59, 10.1007/s11010-016-2733-y Overly, 1995, Quantitative measurement of intraorganelle pH in the endosomal-lysosomal pathway in neurons by using ratiometric imaging with pyranine, Proc Natl Acad Sci U S A, 92, 3156, 10.1073/pnas.92.8.3156 Paisan-Ruiz, 2004, Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease, Neuron, 44, 595, 10.1016/j.neuron.2004.10.023 Papadopoulos, 2018, Modulation of beta-glucocerebrosidase increases alpha-synuclein secretion and exosome release in mouse models of Parkinson's disease, Hum Mol Genet, 27, 1696 Park, 2008, Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease, Glia, 56, 1215, 10.1002/glia.20691 Parton, 1991, pH-induced microtubule-dependent redistribution of late endosomes in neuronal and epithelial cells, J Cell Biol, 113, 261, 10.1083/jcb.113.2.261 Peng, 2015, Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis, J Mol Med, 93, 675, 10.1007/s00109-014-1246-y Polymeropoulos, 1997, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, 276, 2045, 10.1126/science.276.5321.2045 Poteryaev, 2010, Identification of the switch in early-to-late endosome transition, Cell, 141, 497, 10.1016/j.cell.2010.03.011 Purlyte, 2018, Rab29 activation of the Parkinson's disease-associated LRRK2 kinase, EMBO J, 37, 1, 10.15252/embj.201798099 Radulovic, 2018, ESCRT-mediated lysosome repair precedes lysophagy and promotes cell survival, EMBO J, 37, 10.15252/embj.201899753 Rayaprolu, 2013, TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease, Mol Neurodegener, 8, 19, 10.1186/1750-1326-8-19 Reczek, 2007, LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase, Cell, 131, 770, 10.1016/j.cell.2007.10.018 Riederer, 2021, Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease, J Neural Transm (Vienna), 128, 1577, 10.1007/s00702-021-02414-z Robak, 2017, Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease, Brain, 140, 3191, 10.1093/brain/awx285 Rocha, 2020, LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease, Neurobiol Dis, 134, 10.1016/j.nbd.2019.104626 Roodveldt, 2010, Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants, PLoS One, 5, 10.1371/journal.pone.0013481 Rose, 2010, Glycoprotein nonmetastatic B is an independent prognostic Indicator of recurrence and a novel therapeutic target in breast cancer, Clin Cancer Res, 16, 2147, 10.1158/1078-0432.CCR-09-1611 Ryan, 2019, GBA1-associated parkinsonism: new insights and therapeutic opportunities, Curr Opin Neurol, 10.1097/WCO.0000000000000715 Sánchez-Danés, 2012, Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease, EMBO Mol Med, 4, 380, 10.1002/emmm.201200215 Sanyal, 2020, Lysosome and inflammatory defects in GBA1-mutant astrocytes are normalized by LRRK2 inhibition, Mov Disord, 35, 760, 10.1002/mds.27994 Sardiello, 2009, Lysosomal enhancement: a CLEAR answer to cellular degradative needs, Cell Cycle, 8, 4021, 10.4161/cc.8.24.10263 Sardiello, 2009, A gene network regulating lysosomal biogenesis and function, Science, 325, 473, 10.1126/science.1174447 Saric, 2016, mTOR controls lysosome tubulation and antigen presentation in macrophages and dendritic cells, Mol Biol Cell, 27, 321, 10.1091/mbc.e15-05-0272 Seaman, 2007, Identification of a novel conserved sorting motif required for retromer-mediated endosome-to-TGN retrieval, J Cell Sci, 120, 2378, 10.1242/jcs.009654 Settembre, 2012, A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB, EMBO J, 31, 1095, 10.1038/emboj.2012.32 Shin, 2008, LRRK2 regulates synaptic vesicle endocytosis, Exp Cell Res, 314, 2055, 10.1016/j.yexcr.2008.02.015 Sidransky, 2009, Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease, N Engl J Med, 361, 1651, 10.1056/NEJMoa0901281 Skowyra, 2018, Triggered recruitment of ESCRT machinery promotes endolysosomal repair, Science, 360, 10.1126/science.aar5078 Smeyne, 2016, Assessment of the effects of MPTP and Paraquat on dopaminergic neurons and microglia in the substantia Nigra pars compacta of C57BL/6 mice, PLoS One, 11, 10.1371/journal.pone.0164094 Soper, 2011, Aggregation of alpha-synuclein in S. cerevisiae is associated with defects in endosomal trafficking and phospholipid biosynthesis, J Mol Neurosci, 43, 391, 10.1007/s12031-010-9455-5 Spillantini, 1997, Alpha-synuclein in Lewy bodies, Nature, 388, 839, 10.1038/42166 Stefanova, 2011, Toll-like receptor 4 promotes alpha-synuclein clearance and survival of nigral dopaminergic neurons, Am J Pathol, 179, 954, 10.1016/j.ajpath.2011.04.013 Steger, 2016, Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases, Elife, 5, 10.7554/eLife.12813 Sulzer, 2017, T cells from patients with Parkinson's disease recognize α-synuclein peptides, Nature, 546, 656, 10.1038/nature22815 Suresh, 2021, Tubular lysosomes harbor active ion gradients and poise macrophages for phagocytosis, Proc Natl Acad Sci, 118, 10.1073/pnas.2113174118 Swanson, 1987, Tubular lysosome morphology and distribution within macrophages depend on the integrity of cytoplasmic microtubules, Proc Natl Acad Sci U S A, 84, 1921, 10.1073/pnas.84.7.1921 Tang, 2015, VPS35 in dopamine neurons is required for endosome-to-Golgi retrieval of Lamp2a, a receptor of chaperone-mediated autophagy that is critical for alpha-Synuclein degradation and prevention of pathogenesis of Parkinson's disease, J Neurosci, 35, 10613, 10.1523/JNEUROSCI.0042-15.2015 Thévenet, 2011, Regulation of LRRK2 expression points to a functional role in human monocyte maturation, PLoS One, 6, 10.1371/journal.pone.0021519 Tremblay, 2019, Glial phagocytic clearance in Parkinson's disease, Mol Neurodegener, 14, 10.1186/s13024-019-0314-8 Tsika, 2014, Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration, Hum Mol Genet, 23, 4621, 10.1093/hmg/ddu178 Varkey, 2010, Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins, J Biol Chem, 285, 32486, 10.1074/jbc.M110.139576 Vetter, 2001, The guanine nucleotide-binding switch in three dimensions, Science, 294, 1299, 10.1126/science.1062023 Wallings, 2019, LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function, Hum Mol Genet, 28, 2696, 10.1093/hmg/ddz088 Wallis, 2008, MRI assessment of basal ganglia iron deposition in Parkinson's disease, J Magn Reson Imaging, 28, 1061, 10.1002/jmri.21563 Walsh, 2011, Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat, Neuroscience, 175, 251, 10.1016/j.neuroscience.2010.12.005 Winder-Rhodes, 2013, Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort, Brain, 136, 392, 10.1093/brain/aws318 Xiao, 2018, Iron promotes alpha-synuclein aggregation and transmission by inhibiting TFEB-mediated autophagosome-lysosome fusion, J Neurochem, 145, 34, 10.1111/jnc.14312 Yambire, 2019, Impaired lysosomal acidification triggers iron deficiency and inflammation in vivo, Elife, 8, 10.7554/eLife.51031 Yang, 2017, Increased levels of pro-inflammatory and anti-inflammatory cellular responses in Parkinson's disease patients: search for a disease Indicator, Med Sci Monit, 23, 2972, 10.12659/MSM.904240 Yin, 2016, Vps35-dependent recycling of Trem2 regulates microglial function, Traffic, 17, 1286, 10.1111/tra.12451 Youdim, 2004, Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28, Ann N Y Acad Sci, 1012, 306, 10.1196/annals.1306.025 Yu, 2010, Termination of autophagy and reformation of lysosomes regulated by mTOR, Nature, 465, 942, 10.1038/nature09076 Yuseff, 2013, How B cells capture, process and present antigens: a crucial role for cell polarity, Nat Rev Immunol, 13, 475, 10.1038/nri3469 Zavodszky, 2014, Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy, Nat Commun, 5, 3828, 10.1038/ncomms4828 Zhang, 2018, The retromer complex and sorting nexins in neurodegenerative diseases, Front Aging Neurosci, 10, 79, 10.3389/fnagi.2018.00079 Zhao, 2018, Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers, Brain, 141, 486, 10.1093/brain/awx344 Zimprich, 2004, Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology, Neuron, 44, 601, 10.1016/j.neuron.2004.11.005 Zimprich, 2011, A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease, Am J Hum Genet, 89, 168, 10.1016/j.ajhg.2011.06.008